Literature DB >> 1386901

Hepatitis B vaccination in dialysis centres: advantages and limits.

M Rapicetta1.   

Abstract

A review is presented on the results achieved in HBV immunization of hemodialysis patients with aluminum-adsorbed, subunit plasma-derived and yeast-derived vaccines. The main host-related and immunization-related causes of low response are discussed. Various possibility to improve the vaccine performance through appropriate dosage and schedule, as well as immunopotentiating procedures are reported.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1386901     DOI: 10.1159/000186906

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  2 in total

1.  Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system.

Authors:  Masaharu Takahashi; Toshinori Tanaka; Masahiro Azuma; Eiji Kusano; Tatsuya Aikawa; Takao Shibayama; Yasuyuki Yazaki; Hitoshi Mizuo; Jun Inoue; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2007-08-29       Impact factor: 5.948

2.  Serum anti-hepatitis B surface antigen in hemodialysis patients.

Authors:  Mahmoud Rafieian-Kopaei; Hamid Nasri
Journal:  J Nephropharmacol       Date:  2012-01-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.